ATP/P2X7r axis mediates the pathological process of allergic asthma by inducing M2 polarization of alveolar

Ruiting Li1, You Shang1, Xuemei Hu2

  • 1Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, PR China.

Insights

Alveolar macrophages (AMs) polarize to M2 types in asthma, exacerbating inflammation. The ATP/P2X7r axis drives this M2 polarization, suggesting it as a therapeutic target for allergic asthma.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Cell Biology

Background:

  • Macrophages, particularly alveolar macrophages (AMs), play a critical role in respiratory tract immunity.
  • In ovalbumin (OVA)-induced asthma models, AMs are known to polarize towards the M2 phenotype.
  • The ATP/P2X7 receptor (P2X7r) axis is implicated in asthmatic inflammation and Th2 responses.

Purpose of the Study:

  • To investigate the association between the ATP/P2X7r axis and AM polarization in allergic asthma pathogenesis.
  • To determine the specific roles of M1 and M2 AM phenotypes in asthma.
  • To explore the therapeutic potential of targeting the ATP/P2X7r axis.

Main Methods:

  • Established a murine AM-depleted asthma model using clodronate-encapsulated liposomes.
  • Adoptive transfer of M1 or M2 AMs to assess their effects in asthmatic mice.
  • In vivo and in vitro stimulation with OVA, HDM, ATP, Brilliant Blue G, and BzATP to analyze AM polarization and P2X7r activity.

Main Results:

  • Selective depletion of AMs worsened lung inflammation in asthmatic mice.
  • M2-type AMs were identified as key mediators of asthmatic inflammatory responses.
  • P2X7r expression was higher in M2-AMs; its activation promoted M2 polarization and inhibited M1 polarization, while blockage had opposite effects.

Conclusions:

  • Alveolar macrophages differentiate into the M2 phenotype during asthma.
  • The ATP/P2X7r axis is a critical regulator of M2-type AM polarization in allergic asthma.
  • Targeting the ATP/P2X7r axis may offer a novel therapeutic strategy for managing allergic asthma.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.7K